- Home
- AVDL vs BRKL Comparison
AVDL vs BRKL Comparison
Compare AVDL & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- BRKL
- Stock Information
- Founded
- AVDL 2015
- BRKL 1871
- Country
- AVDL Ireland
- BRKL United States
- Employees
- AVDL N/A
- BRKL N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- BRKL Savings Institutions
- Sector
- AVDL Health Care
- BRKL Finance
- Exchange
- AVDL Nasdaq
- BRKL Nasdaq
- Market Cap
- AVDL 784.6M
- BRKL 897.3M
- IPO Year
- AVDL 1996
- BRKL 1998
- Fundamental
- Price
- AVDL $9.43
- BRKL $10.45
- Analyst Decision
- AVDL Strong Buy
- BRKL Buy
- Analyst Count
- AVDL 6
- BRKL 2
- Target Price
- AVDL $18.17
- BRKL $15.25
- AVG Volume (30 Days)
- AVDL 1.3M
- BRKL 469.6K
- Earning Date
- AVDL 05-07-2025
- BRKL 07-23-2025
- Dividend Yield
- AVDL N/A
- BRKL 5.15%
- EPS Growth
- AVDL N/A
- BRKL N/A
- EPS
- AVDL N/A
- BRKL 0.82
- Revenue
- AVDL $194,450,000.00
- BRKL $338,567,000.00
- Revenue This Year
- AVDL $55.11
- BRKL $53.95
- Revenue Next Year
- AVDL $30.13
- BRKL $37.82
- P/E Ratio
- AVDL N/A
- BRKL $12.49
- Revenue Growth
- AVDL 252.64
- BRKL N/A
- 52 Week Low
- AVDL $6.38
- BRKL $8.01
- 52 Week High
- AVDL $17.30
- BRKL $13.15
- Technical
- Relative Strength Index (RSI)
- AVDL 58.38
- BRKL 47.25
- Support Level
- AVDL $8.99
- BRKL $10.14
- Resistance Level
- AVDL $9.31
- BRKL $10.63
- Average True Range (ATR)
- AVDL 0.37
- BRKL 0.21
- MACD
- AVDL -0.01
- BRKL -0.06
- Stochastic Oscillator
- AVDL 74.45
- BRKL 30.69
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.